These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15370937)

  • 1. Unlinking disability income, substance use and adverse outcomes in dually diagnosed, severely mentally ill outpatients.
    Ries RK; Short RA; Dyck DG; Srebnik DS
    Am J Addict; 2004; 13(4):390-7. PubMed ID: 15370937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dropping out of outpatient psychiatric treatment: a preliminary report of a 2-year follow-up of 1500 psychiatric outpatients in Kermanshah, Iran.
    Khazaie H; Rezaie L; de Jong DM
    Gen Hosp Psychiatry; 2013; 35(3):314-9. PubMed ID: 23265950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.
    Ries RK; Dyck DG; Short R; Srebnik D; Fisher A; Comtois KA
    Psychiatr Serv; 2004 Apr; 55(4):445-7. PubMed ID: 15067161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of an outpatient treatment program for dually-diagnosed veterans: the Cincinnati Veterans Affairs Medical Center.
    Sekerka R; Goldsmith RJ; Brandewie L; Somoza E
    J Psychoactive Drugs; 1999; 31(1):85-94. PubMed ID: 10332642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
    Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
    Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders.
    Carrà G; Scioli R; Monti MC; Marinoni A
    Eur Addict Res; 2006; 12(2):96-101. PubMed ID: 16543745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.
    Kelly TM; Daley DC; Douaihy AB
    J Dual Diagn; 2014; 10(3):108-17. PubMed ID: 25392284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual diagnosis patients: substance abuse by the severely mentally ill.
    Smith J; Hucker S
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):650-4. PubMed ID: 8124546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders.
    Kofoed L; Kania J; Walsh T; Atkinson RM
    Am J Psychiatry; 1986 Jul; 143(7):867-72. PubMed ID: 3087222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illness severity and treatment services for dually diagnosed severely mentally ill outpatients.
    Ries RK; Comtois KA
    Schizophr Bull; 1997; 23(2):239-46. PubMed ID: 9165634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence.
    Ho AP; Tsuang JW; Liberman RP; Wang R; Wilkins JN; Eckman TA; Shaner AL
    Am J Psychiatry; 1999 Nov; 156(11):1765-70. PubMed ID: 10553741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severely mentally ill patients with and without substance use disorders: characteristics associated with treatment attrition.
    Primm AB; Gomez MB; Tzolova-Iontchev I; Perry W; Vu HT; Crum RM
    Community Ment Health J; 2000 Jun; 36(3):235-46. PubMed ID: 10933241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness of substance abuse problems among dually-diagnosed psychiatric inpatients.
    RachBeisel J; Dixon L; Gearon J
    J Psychoactive Drugs; 1999; 31(1):53-7. PubMed ID: 10332639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with dual diagnoses or substance use disorders only: 12-step group participation and 1-year outcomes.
    Timko C; Sutkowi A; Moos R
    Subst Use Misuse; 2010 Mar; 45(4):613-27. PubMed ID: 20141467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of treating substance abuse patients with and without comorbid psychiatric disorders.
    Hoff RA; Rosenheck RA
    Psychiatr Serv; 1999 Oct; 50(10):1309-15. PubMed ID: 10506299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment satisfaction compared with outcome in severe dual disorders.
    Ries RK; Jaffe C; Comtois KA; Kitchell M
    Community Ment Health J; 1999 Jun; 35(3):213-21. PubMed ID: 10401891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.